Witnessing the stock’s movement on the chart, on Thursday, GoodRx Holdings Inc (NASDAQ: GDRX) had a quiet start as it plunged -17.51% to $5.04, before settling in for the price of $6.11 at the close. Taking a more long-term approach, GDRX posted a 52-week range of $4.14-$9.26.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
In the past 5-years timespan, the Healthcare sector firm’s annual sales growth was 26.70%. Nevertheless, stock’s Earnings Per Share (EPS) this year is 23.54%. This publicly-traded company’s shares outstanding now amounts to $92.36 million, simultaneously with a float of $81.16 million. The organization now has a market capitalization sitting at $1.91 billion. At the time of writing, stock’s 50-day Moving Average stood at $6.95, while the 200-day Moving Average is $7.29.
GoodRx Holdings Inc (GDRX) Ownership Facts and Figures
Nothing is more important than checking the behaviour of major investors towards the stock of the Health Information Services industry. GoodRx Holdings Inc’s current insider ownership accounts for 78.61%, in contrast to 15.18% institutional ownership. According to the most recent insider trade that took place on Sep 03 ’24, this organization’s 10% Owner sold 10,677 shares at the rate of 7.86, making the entire transaction reach 83,922 in total value, affecting insider ownership by 0.
GoodRx Holdings Inc (GDRX) Earnings and Revenue Records
GoodRx Holdings Inc’s EPS increase for this current 12-month fiscal period is 23.54% and is forecasted to reach 0.43 in the upcoming year.
GoodRx Holdings Inc (NASDAQ: GDRX) Trading Performance Indicators
Let’s observe the current performance indicators for GoodRx Holdings Inc (GDRX). It’s Quick Ratio in the last reported quarter now stands at 7.32. The Stock has managed to achieve an average true range (ATR) of 0.34. Another valuable indicator worth pondering is a publicly-traded company’s price to sales ratio for trailing twelve months, which is currently 2.47. Similarly, its price to free cash flow for trailing twelve months is now 15.04.
In the same vein, GDRX’s Diluted EPS (Earnings per Share) trailing twelve months is recorded -0.14, a figure that is expected to reach 0.10 in the next quarter, and analysts are predicting that it will be 0.43 at the market close of one year from today.
Technical Analysis of GoodRx Holdings Inc (GDRX)
Going through the that latest performance of [GoodRx Holdings Inc, GDRX]. Its last 5-days volume of 2.52 million indicated improvement to the volume of 1.4 million it revealed a year ago. During the previous 9 days, stock’s Stochastic %D was recorded 25.89% While, its Average True Range was 0.39.
Raw Stochastic average of GoodRx Holdings Inc (GDRX) in the period of the previous 100 days is set at 8.26%, which indicates a major fall in contrast to 16.76% during the last 2-weeks. If we go through the volatility metrics of the stock, In the past 14-days, Company’s historic volatility was 84.28% that was higher than 61.26% volatility it exhibited in the past 100-days period.
